| Literature DB >> 31005925 |
Rebecca Beynon1, Martha Maria Christine Elwenspoek1,2, Athena Sheppard1,2, John Nicholas Higgins3, Angelos G Kolias4, Rodney J Laing4, Penny Whiting1,2, William Hollingworth1.
Abstract
OBJECTIVE: Lumbar radiculopathy (LR) often manifests as pain in the lower back radiating into one leg (sciatica). Unsuccessful back surgery is associated with significant healthcare costs and risks to patients. This review aims to examine the diagnostic accuracy of selective nerve root blocks (SNRBs) to identify patients most likely to benefit from lumbar decompression surgery.Entities:
Keywords: diagnostic accuracy of selective nerve root blocks (SNRB); low back pain; lumbar decompression surgery; lumbar radiculopathy
Mesh:
Year: 2019 PMID: 31005925 PMCID: PMC6500311 DOI: 10.1136/bmjopen-2018-025790
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Flowchart of diagnostic study selection process. SNRB, selective nerve root block.
Details of included studies
| Author (year) country | N analysed/N recruited | Description of included patients | Details of previous surgery | Needle level | Anaesthetic details | Guided method | Needle provocation | Number of control injections | Time to pain measurement |
| Within-patient case–control studies | |||||||||
| Yeom | 47/83 | Established single-level radiculopathy. | No history of lumbar surgeries | L3, L4, L5, S1 | 1 mL of 2% lidocaine | Fluoroscopy | No | 1 or 2 | 30 min |
| North | 33/33 | Established sciatica with or without low back pain. History of nerve root compression or imaging findings of ongoing nerve root compression | 48% history of root compression corrected surgically | L5, S1 | 3 mL of 0.5% bupivacaine | Fluoroscopy | Yes | 3 | Every 15 min for 3 hours |
| Prospective diagnostic cohort studies | |||||||||
| Schutz | 15/23 | Current sciatica symptoms | Unclear if patients included in analysis had previous surgeries | NR | 1 mL of procaine (concentration NR) | Guided but method NR | Yes | 1 or 2 | Immediate |
| Retrospective diagnostic cohort studies | |||||||||
| Sasso | 83/83 | Cervical or lumbar radiculopathy. | Unclear how many previous lumbar surgeries | NR | 0.5–0.7 mL of 2% lidocaine | Fluoroscopy | Yes | NR | Immediate |
| Dooley | 62/73 | Radicular pain and previous nerve root infiltration | 32≥1 previous surgery, 3 had 4surgeries | L3, L4, L5, S1 | 1 mL of 1% mepivacaine or lidocaine | Fluoroscopy | Yes | NR | Immediate |
| Williams | 96/100 | Presumed radicular leg pain. | NR | L1, L3, L4, L5, S1 | 2 mL of 1% lidocaine and 0.5–1 mL of Iopamidol | Fluoroscopy | Yes | NR | Immediate |
DRGB, dorsal root ganglion block; NR, not reported; SNRB, selective nerve root block.
Diagnostic accuracy results
| Author (year) | Threshold | Reference standard | TP | FN | Sensitivity % (95% CI) | TN | FP | Specificity % (95% CI) | PLR (95% CI) | NLR (95% CI) |
| Within-patient case-control studies* | ||||||||||
| Yeom | 70% pain relief—several other thresholds also evaluated | Concordant symptoms and imaging evidence of compression (case injections) or no symptoms or imaging evidence of compression (control injections) | 27 | 20 | 57 (43 to 70) | 50 | 8 | 86 (75 to 93) | 4.1 (2.1 to 8.3) | 0.5 (0.4 to 0.7) |
| North | 50% reduction in baseline pain following block | Concordant symptoms and imaging evidence of compression (case injections) or no symptoms or imaging evidence of compression (control injections) | 30 | 3 | 91 (76 to 97) | 8 | 25 | 24 (12 to 41) | 1.2 (1.0 to 1.5) | 0.4 (0.1 to 1.3) |
| Diagnostic cohort studies | ||||||||||
| Schutz | 100% pain relief. Full trunk flexion and straight leg raising possible | Intraoperative findings | 12 | 0 | 100 (76 to 100) | 1 | 2 | 33 (6 to 79) | 1.5 (0.7 to 3.3) | 0.0 |
| Sasso | Visual Analogue Scale score 0–1 and immediate relief of >95% pain | Outcome 12 months following surgery | 71 | 3 | 96 (89 to 99) | 5 | 4 | 56 (27 to 81) | 2.2 (1.0 to 4.5) | 0.1 (0.0 to 0.3) |
| Dooley | Pain relief | Intraoperative surgical confirmation of root pathology | 46 | 4 | 92 (81 to 98) | 2 | 1 | 67 (9 to 99) | 2.8 (0.6 to 13.7) | 0.1 (0.0 to 0.4) |
| Outcome following surgery (follow-up range 24–36 months) | 28 | 4 | 88 (71 to 96) | 2 | 19 | 10 (1 to 30) | 1.0 (0.8 to 1.2) | 1.2 (0.3 to 6.5) | ||
| Williams | Pain relief | Outcome 3 months following surgery (resolution of symptoms) | 41 | 7 | 85 (72 to 94) | 2 | 10 | 17 (3 to 48) | 1.0 (0.8 to 1.4) | 0.9 (0.2 to 3.7) |
*Please note that the unit used in the within-patient case–control studies is number of injections and some patients had two control injections at adjacent levels in addition to the affected nerve; in all other studies it is number of patients.
FN, false negative; FP, false positive; NLR, negative likelihood ratio; PLR, positive likelihood ratio; TN, true negative; TP, true positive.
QUADAS-2 results
| Author (year) | Risk of bias | Applicability concerns | |||||
| Patient selection | Index test | Reference standard | Flow and timing | Patient selection | Index test | Reference standard | |
| Within-patient case-control studies | |||||||
| Yeom |
|
|
|
|
|
|
|
| North |
|
|
|
|
|
|
|
| Diagnostic cohort studies | |||||||
| Sasso |
|
|
|
|
|
|
|
| Schutz |
|
|
|
|
|
|
|
| Dooley |
|
|
|
|
|
|
|
| Williams |
|
|
|
|
|
|
|
, low risk/concern; , high risk/concern; ?, unclear risk/concern.
Figure 2ROC plot displaying diagnostic accuracy results of included studies. CI, control injection reference standard; IO, intraoperative reference standard; PS, postsurgical reference standard; ROC, receiver-operating characteristic.